Wednesday, October 14, 2026

Block Pivots to AI Payments as Pelican Processes 1B+ Transactions Across 55 Countries

Financial technology firms are restructuring around AI-driven payment processing and compliance infrastructure. Pelican Canada processes over 1 billion transactions across 55 countries using 25 years of AI expertise, while Block announces workforce restructuring to accelerate its AI pivot. Regulatory clarity expected by Q2 2026 will enable widespread AI adoption for liquidity optimization and fraud detection.

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
Block Pivots to AI Payments as Pelican Processes 1B+ Transactions Across 55 Countries
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Pelican Canada has processed more than one billion transactions across 55 countries using AI-driven payment processing and financial crime compliance systems built over 25 years. The infrastructure handles multiple payment types and global banking standards, positioning the company as a reference point in the industry's shift toward automated compliance and real-time processing.

Block recently announced a major AI pivot accompanied by workforce restructuring, signaling that established fintechs are redeploying resources toward machine learning capabilities. The move reflects mounting pressure from cost reduction needs and competitive dynamics in payment processing.

The transformation centers on three technical areas: AI-powered fraud detection, liquidity optimization through real-time analytics, and compliance automation. Payment processors are embedding machine learning models directly into transaction flows rather than treating AI as a separate layer.

Programmable money infrastructure using stablecoins and blockchain technology is enabling new treasury management capabilities. These systems allow corporate treasurers to automate cash positioning and execute payment rules without manual intervention.

Ripple CEO Brad Garlinghouse stated he previously estimated regulatory clarity by "end of April," though he acknowledged "people thought that was a little optimistic." The industry now expects comprehensive crypto payment regulation by Q2 2026, which would establish compliance frameworks for AI-driven stablecoin systems.

The regulatory timeline matters because banks require legal certainty before integrating AI payment rails at scale. Current systems operate in pilot mode or under limited licenses.

Payment processors with AI capabilities are gaining transaction volume as volatility pressures companies to reduce fraud losses and optimize working capital. Traditional processors without machine learning infrastructure face margin compression.

The infrastructure buildout is accelerating across three layers: AI models for transaction risk scoring, APIs for programmable payment logic, and blockchain settlement rails. Companies implementing all three layers are processing higher volumes at lower unit costs than those using legacy systems.

Market trajectory shows active acceleration with established players restructuring and specialized AI payment processors scaling rapidly. The Q2 2026 regulatory deadline will determine which companies have deployable infrastructure versus vaporware.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleCrunchbase News
    5 Interesting Startup Deals You May Have Missed: Plant-Based Clothing Dyes, A Shoebox-Picking Robot, And Power Generated On The Moon
  2. [2]News articleYahoo Finance· February 24, 2026
    Agentic AI Foundation Welcomes 97 New Members As Demand for Open, Collaborative Agent Standardization Increases
  3. [3]News articleYahoo Finance· December 24, 2025
    In 2026, CFOs predict AI transformation, not just efficiency gains
  4. [4]News articleYahoo Finance· February 23, 2026
    Ocham's Razor Capital Limited Announces Reverse Takeover Transaction With Pelican Canada Inc. and Brokered Financing
  5. [5]News articleYahoo Finance· February 23, 2026
    Pure Storage Becomes Everpure; Announces Intent to Acquire 1touch
  6. [6]News articleYahoo Finance· February 23, 2026
    Ripple CEO: 90% Chance Crypto Bill Passes By April, But What Do Prediction Markets Say?
  7. [7]News articleYahoo Finance· February 23, 2026
    Super Group Reports Financial Results for Fourth Quarter and Full Year 2025
  8. [8]News articleYahoo Finance· December 10, 2025
    Under attack: How AP leaders can stop phony bank account change requests
  9. [9]News articleYahoo Finance· January 11, 2026
    Warren Buffett once explained how to turn $10K into a fortune for new investors. 3 strategies that still hold up in 2026
  10. [10]Press releaseGlobeNewswire· February 17, 2026
    13,000 strong: AIBC Eurasia 2026 sets the stage for a bigger 2027
  11. [11]News articleYahoo Finance· February 22, 2026
    5 big analyst AI moves: Nvidia stock ’likely to outperform in 2H26’
  12. [12]News articleYahoo Finance· February 26, 2026
    Earnings live: Block stock surges over 20% after Jack Dorsey cuts nearly half of staff, Dell stock jumps
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com